M., Bhasin, S., Flevaris, P., Mitchell, L
Conclusions These data confirm the efficacy and safety profile of OW semaglutide (0.5 and 1.0 mg) versus OD sitagliptin by improving both glycaemic control and reducing body weight in a Korean population with T2D
Some people eat too little, especially during dose changes or early nausea
37.1% achieved HbA1c below 5.7% vs 12.5% with oral semaglutide
Compounded The drug menu is still the biggest fork in the road between these two providers, but the gap has narrowed a bit in 2026 as oral options and shortage-era workarounds have expanded
Cardiovascular exercise (walking, jogging, cycling, swimming) also supports your health during GLP-1 treatment by improving cardiovascular fitness, supporting mental health, and contributing to caloric expenditure